相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Bone Volume, FGF23 and Sclerostin in Calcifications and Mortality; a Cohort Study in CKD Stage 5 Patients
Ana Carina Ferreira et al.
CALCIFIED TISSUE INTERNATIONAL (2022)
The role of static bone histomorphometry in diagnosing renal osteodystrophy
Syazrah Salam et al.
BONE (2021)
The Non-invasive Diagnosis of Bone Disorders in CKD
Jordi Bover et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
The Role of Bone Biopsy in the Management of CKD-MBD
Ana Carina Ferreira et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Bone Mineral Disease After Kidney Transplantation
Josep-Vicent Torregrosa et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Bone densitometry versus bone histomorphometry in renal transplanted patients: a cross-sectional study
Ana Carina Ferreira et al.
TRANSPLANT INTERNATIONAL (2021)
Performance of soluble Klotho assays in clinical samples of kidney disease
Javier A. Neyra et al.
CLINICAL KIDNEY JOURNAL (2020)
Bone alkaline phosphatase: An important biomarker in chronic kidney disease - mineral and bone disorder
Adrien Nizet et al.
CLINICA CHIMICA ACTA (2020)
Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples
Etienne Novel-Catin et al.
BONE (2020)
Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race
Emilia M. D. Soeiro et al.
PEDIATRIC NEPHROLOGY (2020)
Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients
Pieter Evenepoel et al.
KIDNEY INTERNATIONAL (2019)
Changes in Bone Histomorphometry after Kidney Transplantation
Satu Keronen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Fibroblast growth factor 23 expression in human calcified vascular tissues
Javier Donate-Correa et al.
AGING-US (2019)
A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation
Igor Denizarde Bacelar Marques et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Circulating markers of bone turnover
Marc G. Vervloet et al.
JOURNAL OF NEPHROLOGY (2017)
Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation
Pieter Evenepoel et al.
KIDNEY INTERNATIONAL (2017)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder
Rosa M. A. Moyses et al.
SEMINARS IN DIALYSIS (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody
Sarah L. Barker et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Importance of Vascular Calcification Kidney Transplant Recipients
Giuseppe Cianciolo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Flavia Leticia Carvalho Goncalves et al.
BMC NEPHROLOGY (2014)
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
Marc G. Vervloet et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
CKD-Mineral and Bone Disorder Management in Kidney Transplant Recipients
Hala M. Alshayeb et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Julia J. Scialla et al.
KIDNEY INTERNATIONAL (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Sclerostin in CKD-MBD: one more paradoxical bone protein?
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients
Pieter Evenepoel
SEMINARS IN NEPHROLOGY (2013)
Persistence of Bone and Mineral Disorders 2 Years After Successful Kidney Transplantation
Carolina L. Neves et al.
TRANSPLANTATION (2013)
Renal Osteodystrophy in the First Decade of the New Millennium: Analysis of 630 Bone Biopsies in Black and White Patients
Hartmut H. Malluche et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
CKD-MBD after kidney transplantation
Katherine Wesseling-Perry et al.
PEDIATRIC NEPHROLOGY (2011)
Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation
Wacharee Seeherunvong et al.
PEDIATRIC TRANSPLANTATION (2011)
Bone disease after renal transplantation
Hartmut H. Malluche et al.
NATURE REVIEWS NEPHROLOGY (2010)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Renal osteodystrophy after successful renal transplantation: A histomorphometric analysis in 57 patients
G. Lehmann et al.
TRANSPLANTATION PROCEEDINGS (2007)
Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation
K. Borchhardt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
E. Canalis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Improvement of adynamic bone disease after renal transplantation
KA Abdallah et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients
T Adragao et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Bone disease in long-term adult kidney transplant patients with normal renal function
C Montalban et al.
KIDNEY INTERNATIONAL (2003)
The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling
E Rojas et al.
KIDNEY INTERNATIONAL (2003)
Renal osteodistrophy:: Histologic evaluation after renal transplantation
L Martins et al.
TRANSPLANTATION PROCEEDINGS (2000)
Bone disease in patients with long-term renal transplantation and normal renal function
RG Carlini et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
